Poolbeg Pharma (LON:POLB) Trading Up 13.4% – Here’s What Happened

Shares of Poolbeg Pharma PLC (LON:POLB) traded up 13.4% during trading on Tuesday . The stock traded as high as GBX 5 ($0.06) and last traded at GBX 4.42 ($0.05). 9,764,975 shares traded hands during trading, a decline of 44% from the average session volume of 17,505,164 shares. The stock had previously closed at GBX 3.90 ($0.05).

Wall Street Analyst Weigh In

Separately, Shore Capital reiterated a “house stock” rating on shares of Poolbeg Pharma in a report on Thursday, January 2nd.

Poolbeg Pharma Stock Performance

The company has a market capitalization of £26.98 million, a PE ratio of -539.50 and a beta of 2.11. The business has a fifty day moving average price of GBX 7.30 and a 200 day moving average price of GBX 9.78.

About Poolbeg Pharma

Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation.

Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value.